DATE: April 27, 2011
LOCATION: BioPharmaceutical Technology Center, Madison, WI
COORDINATORS: University of Wisconsin Stem Cell & Regenerative Medicine Center; BioPharmaceutical Technology Center Institute
OVERVIEW: Coordinated by the University of Wisconsin Stem Cell & Regenerative Medicine Center and BTC Institute, this symposium brings together world leaders in the area of cellular reprogramming. The focus is on using intracellular or extracellular cues to manipulate gene regulation and control stem cell pluripotency and lineage-specific differentiation.
Wisconsin Stem Cell Symposium
Forbes Magazine provided additional confirmation that adult stem cell research is far more successful that embryonic stem cell experimentation. In their September 3, 2001 issue, page 36, they quoted an article printed in the Wall Street Journal Europe by Richard Miniter.
"Of the 15 US biotech companies solely devoted to developing cures using stem cells, only two focus on embryos. Embryo stem cell research is at the drawing-board stage - not for lack of funds but for lack of promising research to finance. Venture capitalists have no agenda beyond making money; if they see embryo projects that are likely to bear fruit over the next five to seven years - the usual VC time horizon - they will fund them. That the market is speaking so loudly against embryo stem cell research probably explains why embryo researchers are so eager to reverse the ban on government funding."
Life Issues
No comments:
Post a Comment